Skip to content

Clinical trials

Central Nervous System Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Canada Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20103
20122
20133
20144
20152
20164
20172
20183
20192
20204
20213
20221
20234
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated8
Recruiting4
Active, not recruiting3
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia4
AbbVie3
AstraZeneca3
GlaxoSmithKline3
Centre hospitalier de l'Université de Montréal (CHUM)2
Eli Lilly and Company2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
University Health Network, Toronto2
AbbVie (prior sponsor, Abbott)1
Alzheon Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases42
Brain Diseases34
Nervous System Diseases32
Neurodegenerative Diseases16
Cerebrovascular Disorders12
Mental Disorders12
Alzheimer Disease11
Movement Disorders11
Cardiovascular Diseases10
Dementia10

Trials

Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.